Activin-βC modulates gonadal, but not adrenal tumorigenesis in the inhibin deficient mice

Molecular and Cellular Endocrinology

Volumn 409, Issue , 2015, Pages 41-50

  Marino, Francesco Elia ^a   Risbridger, Gail ^b   Gold, Elspeth ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Adrenal; Gonadectomy; Inhibin; Ovaries; Testis; Tumor

Indexed keywords

ACTIVIN; ACTIVIN A; ACTIVIN BETA SUBUNIT C; ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR 2B; FOLLISTATIN; INHIBIN; SMAD2 PROTEIN; UNCLASSIFIED DRUG; INHBC PROTEIN, MOUSE; INHIBIN BETA A SUBUNIT;

ADRENAL CORTEX; ADRENAL CORTEX CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GONAD; HOMEOSTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; UPREGULATION; ADRENAL TUMOR; ANIMAL; DEFICIENCY; GONAD TUMOR; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SURGERY; SURVIVAL;

ADRENAL GLAND NEOPLASMS; ANIMALS; FEMALE; GONADS; INHIBIN-BETA SUBUNITS; MALE; MICE; MICE, KNOCKOUT; NEOPLASMS, GONADAL TISSUE; SURVIVAL ANALYSIS;

EID: 84928121807     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.04.004     Document Type: Article

References (37)

1. Arola J., Liu J., Heikkila P., Ilvesmaki V., Salmenkivi K., Voutilainen R., et al. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm. J. Endocrinol 2000, 165:223-229.
2. Beuschlein F., Looyenga B.D., Bleasdale S.E., Mutch C., Bavers D.L., Parlow A.F., et al. Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol. Cell. Biol 2003, 23:3951-3964.
3. Beuschlein F., Looyenga B., Reincke M., Hammer G. Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis. Horm. Metab. Res 2004, 36:392-396.
4. Bukowski R.M., Wolfe M., Levine H.S., Crawford D.E., Stephens R.L., Gaynor E., et al. Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study. J. Clin. Oncol 1993, 11:161-165.
5. Choi Y.-L., Kim H.-S., Ahn G. Immunoexpression of Inhibin α Subunit, Inhibin/Activin βA Subunit and CD99 in Ovarian Tumors. Arch. Pathol. Lab. Med 2000, 124:563-569.
6. Counihan N.A., Rawlinson S.M., Lindenbach B.D. Trafficking of hepatitis C virus core protein during virus particle assembly. PLoS Pathog 2011, 7:e1002302.
7. Dackiw A.P., Lee J.E., Gagel R.F., Evans D.B. Adrenal cortical carcinoma. World J. Surg 2001, 25:914-926.
8. Elliott R.L., Blobe G.C. Role of transforming growth factor beta in human cancer. J. Clin. Oncol 2005, 23:2078-2093.
9. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol 1992, 119:493-501.
10. Gold E., Jetly N., O'Bryan M.K., Meachem S., Srinivasan D., Behuria S., et al. Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo. Am. J. Pathol 2009, 174:184-195.
11. Gold E., Marino F.E., Harrison C., Makanji Y., Risbridger G. Activin-βc reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice. J. Pathol 2013, 229:599-607.
12. Gold E.J., Zhang X., Wheatley A.M., Mellor S.L., Cranfield M., Risbridger G.P., et al. betaA- and betaC-activin, follistatin, activin receptor mRNA and betaC-activin peptide expression during rat liver regeneration. J. Mol. Endocrinol 2005, 34:505-515.
13. Grumbach M.M., Biller B.M., Braunstein G.D., Campbell K.K., Carney J.A., Godley P.A., et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann. Intern. Med 2003, 138:424-429.
14. Hofland J., de Jong F.H. Inhibins and activins: their roles in the adrenal gland and the development of adrenocortical tumors. Mol. Cell. Endocrinol 2012, 359:92-100.
15. Hofland J., Timmerman M.A., De Herder W.W., Van Schaik R.H.N., De Krijger R.R., De Jong F.H. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms. Clin. Endocrinol. (Oxf) 2006, 65:792-799.
16. Lau A.L., Kumar T.R., Nishimori K., Bonadio J., Matzuk M.M. Activin βC and βE genes are not essential for mouse liver growth, differentiation, and regeneration. Mol. Cell. Biol 2000, 20:6127-6137.
17. Ling N., Ying S.Y., Ueno N., Esch F., Denoroy L., Guillemin R. Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid. PNAS 1985, 82:7217-7221.
18. Lipsett M.B., Hertz R., Ross G.T. Clinical and pathophysiologic aspects of adrenocortical carcinoma. Am. J. Med 1963, 35:374-383.
19. Looyenga B.D., Hammer G.D. Origin and identity of adrenocortical tumors in inhibin knockout mice: implications for cellular plasticity in the adrenal cortex. Mol. Endocrinol 2006, 20:2848-2863.
20. Looyenga B.D., Wiater E., Vale W., Hammer G.D. Inhibin-A antagonizes TGFβ2 signaling by down-regulating cell surface expression of the TGFβ coreceptor betaglycan. Mol. Endocrinol 2010, 24:608-620.
21. Makarev E., Gorivodsky M. Islet1 and its co-factor Ldb1 are expressed in quiescent cells of mouse intestinal epithelium. PLoS ONE 2014, 9:e95256.
22. Mantero F., Terzolo M., Arnaldi G., Osella G., Masini A.M., Alì A., et al. A survey on adrenal incidentaloma in Italy 1. J. Clin. Endocrinol. Metab 2000, 85:637-644.
23. Marino F.E., Risbridger G., Gold E. The inhibin/activin signalling pathway in human gonadal and adrenal cancers. Mol. Hum. Reprod 2014, 20:1223-1237.
24. Massagué J. TGF-β signal transduction. Annu. Rev. Biochem 1998, 67:753-791.
25. Massague J. How cells read TGF-[beta] signals. Nat. Rev. Mol. Cell Biol 2000, 1:169-178.
26. Matzuk M., Finegold M., Mather J., Krummen L., Lu H., Bradley A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. PNAS 1994, 91:8817-8821.
27. Matzuk M.M., Finegold M.J., Su J.-G.J., Hsueh A.J.W., Bradley A. alpha-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992, 360:313-319.
28. McPherson S.J., Hussain S., Balanathan P., Hedwards S.L., Niranjan B., Grant M., et al. Estrogen receptor-β activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFα mediated. PNAS 2010, 107:3123-3128.
29. Mellor S.L., Cranfield M., Ries R., Pedersen J., Cancilla B., De Kretser D., et al. Localization of activin βA-,β B-, and β C-subunits in human prostate and evidence for formation of new activin heterodimers of β C-subunit. J. Clin. Endocrinol. Metab 2000, 85:4851-4858.
30. Miyamoto K., Hasegawa Y., Fukuda M., Nomura M., Igarashi M., Kangawa K., et al. Isolation of porcine follicular fluid inhibin of 32K daltons. Biochem. Biophys. Res. Commun 1985, 129:396-403.
31. Rivier J., Spiess J., McClintock R., Vaughan J., Vale W. Purification and partial characterization of inhibin from porcine follicular fluid. Biochem. Biophys. Res. Commun 1985, 133:120-127.
32. Robertson D.M., Foulds L.M., Leversha L., Morgan F.J., Hearn M.T.W., Burger H.G., et al. Isolation of inhibin from bovine follicular fluid. Biochem. Biophys. Res. Commun 1985, 126:220-226.
33. Spencer S.J., Rabinovici J., Mesiano S., Goldsmith P.C., Jaffe R.B. Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. J. Clin. Invest 1992, 90:1420149.
34. Spencer S.J., Mesiano S., Lee J.Y., Jaffe R.B. Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling 1. The J. Clin. Endocrinol. Metab 1999, 84:1110-1115.
35. Vanttinen T., Liu J., Kuulasmaa T., Kivinen P., Voutilainen R. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis. J. Endocrinol 2003, 178:479-489.
36. Voutilainen R., Erämaa M., Rivtos O. Hormonally regulated inhibin gene expression in human fetal and adult adrenals. J. Clin. Endocrinol. Metab 1991, 73:1026-1030.
37. Woodruff T.K., Krummen L., Chen S.A., Lyon R., Hansen S.E., Deguzman G., et al. Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I] rh-inhibin A and [125I] rh-activin A in immature female and male rats. Endocrinology 1993, 132:725-734.